P. Karp

Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.

Huidong Shi, C. Caldwell, J. Engelhardt, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Immunohistochemical Detection of Markers for Translational Studies of Lung Disease in Pigs and Humans

D. Meyerholz, M. Welsh, D. Stoltz, 2016, Toxicologic pathology.

Development of cystic fibrosis and noncystic fibrosis airway cell lines.

M. Welsh, J. Zabner, A. Klingelhutz, 2003, American journal of physiology. Lung cellular and molecular physiology.

The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.

M. Welsh, D. Look, J. Zabner, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung

M. Welsh, T. Moninger, C. Wohlford-Lenane, 2012, Nature.

Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro.

M. Welsh, J. Widdicombe, J. Zabner, 1998, Molecular cell.

KGF alters gene expression in human airway epithelia: potential regulation of the inflammatory response.

M. Welsh, T. Moninger, L. Prince, 2001, Physiological genomics.

Defective fluid transport by cystic fibrosis airway epithelia.

M. Welsh, J. J. Smith, P. Karp, 1994, The Journal of clinical investigation.